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Abstract Age related cataract is the leading cause of blindness associated with accumulation of oxidative stress in the
eye lens. The present investigation reveals the rational of the beneficial effects of the natural compound C-phycocyanin (C-
PC) is beneficial when administered to rat pups to protect against the secondary effects of sodium selenite induced
cataractogenesis. A single subcutaneous dose of sodium selenite (19 lmol/kg body weight) on the 10th day of postpartum
is adequate to induce cataract in rat pups. Serum biochemical parameters, such as the level of electrolytes, mean activities
of anti-oxidant enzymes i.e. superoxide dismutase, catalase and reduced glutathione were observed to be significantly
altered during selenite induced cataractogenic process. Histopathological examination revealed signs of degradation of
normal cell architecture in the liver, kidney and eye lens. Interestingly, the deleterious effects of sodium selenite toxicity
were restored with the simultaneous treatment with C-PC. The results suggest that an administration of 200 mg/kg body
weight of C-PC has the ability to prevent/alter the secondary changes reflected in the serum biochemical and histological
modifications in rats exposed to sodium selenite. These results complement the beneficial role of C-PC of cyanobacterial
origin as a efficacious anti-cataractogenic agent against sodium selenite toxicity.
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1 Introduction
Age related cataract is a common non-infectious disease of
the eye lens, characterized by abnormalities in membrane
permeation, protein aggregation, loss of glutathione redox
system, imbalance in electrolytes transport, distorted cal-
cium homeostasis, decreased enzyme activity and ATP
content [1]. It accounts for more than 42 % of visual
impairment and vision loss globally [2]. At the crux of the
disease is the loss of endogenous reduced glutathione;
however the lens epithelial cells tend to be resilient to
vision loss. Further, the cataractogenic stimulus is over-
ridden by a magnitude of oxidative stress which leads to
the complete opacification of the lens [3]. Aging [4],
smoking [5], exposure to radiation [6], and accumulation of
metabolites [7] are some of the major environmental stress
that cause cataractogenesis. Until recently, the surgical
removal of the lens and implantation of an artificial intra-
ocular lens is the main treatment of cataract [8]. However,
surgical management inevitably result in a number of
complications, such as keratopathy, postoperative glau-
coma, retinal detachment, loss of accommodative power,
and endophthalmitis [9].
A single dosage of sodium selenite (19 lmol/kg body
weight) has been shown to be an ideal animal model to
study in vivo cataractogenesis for the past decade as it
reflects human senile cataract in all aspects. Sodium sele-
nite has the potential to induce severe bilateral cataract in
10-day-old rat pups, on receiving a single subcutaneous
injection of 19 lmol/kg body weight [1]. Mechanistically,
exogenous selenite reacts with glutathione, the most
R. P. Kumari  K. Anbarasu (&)
Department of Marine Biotechnology, Bharathidasan University,
Tiruchirappalli 620024, Tamil Nadu, India
e-mail: anbumbt@bdu.ac.in
123
Nat. Prod. Bioprospect. (2014) 4:81–89
DOI 10.1007/s13659-014-0008-4
abundant physiological sulfhydryl compound to form
seleno-trisulfide which accumulates in elevated oxidative
stress [10]. Selenium is an intrinsic component of gluta-
thione peroxidase that reduces H2O2 to water at the con-
version of GSH to GSSH (oxidized glutathione). However
oxidative stress imparted by sodium selenite creates reac-
tive oxygen species that induces a progressive decline of
vision. Exposure of rats to sodium selenite has shown
drastic changes in the hematological and biochemical
parameters [11]. Sodium selenite has been documented to
trigger early lenticular epithelial cell damage including loss
of calcium homeostasis [12], crystallin protein breakdown
[13], loss of anti-oxidant enzyme activity, accelerated
apoptosis and DNA damage.
The only treatment available for cataract to date is the
surgical removal of the opacified lens and its replacement
with a synthetic intra ocular lens that demands a skilled
surgeon and post operational issues as mentioned previ-
ously. However, recent research has been focused on the
search for a prophylactic or therapeutic natural compound
to treat/prevent cataractogenesis [1]. Natural compounds
with beneficial properties and minimal side effects are
gaining attention, in particular one such anti-oxidant;
C-PC, is a soluble billiprotein present in Spirulina platensis
and other cyanobacteria. Moreover, S. platensis has gained
worldwide attention due to its nutraceutical attributes such
as high quality protein, c-linoleic acid, carotenoids, vita-
min B12 and B2 [14]. C-PC is an accessory pigment of the
light harvesting complex, which captures light energy and
transfers it to chlorophyll a [15]. C-PC has been reported to
possess anti-oxidant [16], neuroprotective [17], anti-
inflammatory [18], hepatoprotective [19], anti-arthritic
properties [20]. In our previous study, we revealed that
C-PC isolated from S. platensis is capable of preventing the
incidence of selenite induced cataractogenesis by in vitro
morphological analysis and anti-oxidant enzyme modula-
tion [21]. In this study we aim to determine the potentiality
of C-PC to protect against the secondary in vivo changes
imposed during selenite cataracteous conditions and to
define the protective efficacy of C-PC on organs histology
and serum parameters related to senile cataractogenesis.
2 Results and Discussion
2.1 Plot Profile Analysis
Morphological and ImageJ software analysis (http://
rsbweb.nih.gov/ij/) testified that when compared to the
control animals (group I), sodium selenite administrated
rats developed dense opacification of the lens (group II).
Interestingly, group III revealed minimal area of cataract
distribution on treatment with 200 mg/kg body weight of
C-PC compared to group II rat eye lens. The plot profile
analysis also indicated a minimal opacification in the rat
lens treated with C-PC (Fig. 1) when compared to the
Group II. The data presented suggests secondary impact on
histological sections of liver and kidney caused by subcu-
taneous injection of sodium selenite (Fig. 1). In the epi-
thelial cells (E), they were intact in the normal lens of
control group showing distinct demarcation between the
cortex (C) and nucleus (Fig. 2). Whereas prominent his-
tological architectural alterations such as fragmented fiber
cells and the cortex was observed in the cataracteous lens
in group II (sodium selenite induced animals). Deep cor-
tical vacuolization (V) was observed in group II rat lens,
which is the phenomenal effect of aggregated crystallin and
other lenticular proteins. With C-PC treatment (group III),
the micro- architecture of the lens was significantly pro-
tected from oxidative damage induced by sodium selenite
toxicity. Our results corroborate with the previous findings
of Anderson et al. [22], showing aggregated proteins and
vacuoles formation in the cortex region of the eye lens
histological sections. The histological lesion in the cortex
is possibly due to oxidative stress induced proteolysis and
enhanced lipid peroxidation.
2.2 Serum Enzyme Activities
Recently, Tripathi et al. [23] demonstrated that liver
function abnormality is caused by elevated serum ALT,
AST, ALP and bilirubin. Moreover, the liver is the major
organ site of sodium selenite toxicity, where altered
enzyme synthesis, release and catabolism of serum
enzymes are major effectors and markers of cellular dam-
age caused by oxidative stress. The serum enzymes were
monitored to ascertain normal hepatic function. The mean
activities of liver enzymes such as alkaline phosphatase
Fig. 1 Plot profiles generated by ImageJ showed cataract distribution
(y-axis) relative to the distance from the center of the lens (x-axis)
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(ALP), alanine transaminase (ALT), aspartate transaminase
(AST) and gamma-glutamyl transpeptidase (GGT) were
significantly elevated in sodium selenite induced group of
animals (Table 1). Nevertheless, the enzyme activities
were restored as to that of normal levels on simultaneous
C-PC treatment (group III). A similar trend was observed
with the activities of amylase, lipase and creatinine kinase
(CK) (Table 1). Particularly the levels of CK, a marker
enzyme of heavy metal toxicity was increased three-fold in
the sodium selenite induced group when compared to the
control and C-PC treated groups.
Histology of liver tissue obtained from control, selenite
induced and C-PC treated rat pups were imaged under 109
(a–c) and 409 (d–f) magnifications. The liver section of
control animals shows normal lobular architecture of the
hepatocytes arranged around the portal canal (PC) with fine
arrangement of Kupffer cells demonstrating normal pat-
tern. However, in sodium selenite induced cataract group
(group II) animals developed apoptotic changes such as
nuclear shrinkage, pyknotic nucleus (PN) and dilations in
blood sinusoid (DBS) in heptocytes. Higher magnification
of liver sections from selenite induced and C-PC treated
group (group III) reveals only a few degenerated
hepatocytes and the conventional pattern of tissue was
preserved (Fig. 3).
Release of metabolizing enzymes into the blood stream
and damaged microscopic anatomy of the liver are signa-
tures of compromised liver function exerted by sodium
selenite toxicity. Amylase and lipase are pancreatic
enzymes involved in the digestion and absorption of
nutrients. ALP is an early indicator of hepato-cellular
damage, since it can be easily mobilized into the blood at
the onset of damage [24]. This anomaly is a consequence
of hepatic dysfunction, however on C-PC treatment in
group III, the serum components were conserved signifi-
cantly. In the present study, the liver biomarker enzymes
were elevated in sodium selenite induced group. This is an
aftermath effect of oxidative stress exerted by sodium
selenite toxicity, which certainly reflects on the liver cell
morphology.
CK is one of the target enzymes for reactive oxygen
species, plays a key role in energy metabolism of tissues
[25] and this enzyme is moderately elevated in the serum
due to liver damage. A three-fold increase in serum CK in
group II animals denotes muscular and liver damage
caused by oxidative stress. Nonetheless, treatment with
Fig. 2 Histo-architecture of eye lens tissue: viewed under 109
magnification (a–c) and 409 magnification (d–f). Eye lens section of
control group shows a organized lining of lens epithelial cells (E) and
uniform staining of the fiber cells and cortex (C). Sodium selenite
induced group II rat lens shows distinct vacuoles (V) and disorganized
epithelial cells (DE) which is the hallmark of lens protein aggregation
and opacification. However, the group III (treated with C-PC)
revealed significant restoration of lenticular micro-architecture
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C-PC (200 mg/kg body weight) has proven to restore the
normal architecture of the hepatocytes and the levels of
enzymes were maintained significantly equivalent to con-
trols in group III. In agreement with the current findings,
C-PC is reported to depress/reduce liver injury caused by
carbon tetrachloride in animals [19]. This property is un-
derpinned by the reduced rate of biotransformation of toxic
species or by scavenging the reactive metabolites produced
by oxidative stress [26].
2.3 Serum Protein Metabolism
Total protein, albumin and globulin levels were assessed to
probe the extent of alteration in protein metabolism. The
protein content was decreased in the selenite induced group
(group II) however, the levels were maintained at near
normal level on simultaneous treatment of C-PC (group III)
(Table 1). The serum total protein, globulin and albumin
were decreased in rat pups due to the impact of sodium
selenite administration due to altered intracellular protein
synthesis and metabolism [25].
2.4 Selected Serum Electrolytes
Electrolytes influence many vital body functions; a
dynamic balance of electrolytes in sera imparts a major
role in normal physiology and cellular territorial integrity.
However, the levels of sodium, phosphorous, magnesium,
bicarbonate and calcium were altered in the group II rats
induced with sodium selenite (Table 1). Other electrolytes
such as phosphorous and chloride were found to be
imbalanced in group II rats. In the C-PC treated group
(group III) such fluctuation was not observed in the levels
of electrolytes, which was almost equivalent to the control
group (group I). Certainly, fluctuations in electrolytes
balance are pathological, whereas a compromised kidney
performance is also reflected in an imbalance of electro-
lytes. Ca2? is a vital secondary messenger and electrolyte











ALT (U/L) 36.82 ± 1.57 432.67 ± 2.51a,c 39.06 ± 1.36b,d
AST (U/L) 19.33 ± 1.52 232.67 ± 2.67a,c 22.47 ± 2.08b,d
GGT (mg/dL) 30.33 ± 1.52 63.58 ± 0.58a,c 33.25 ± 2.08b,d
ALP (mg/dL) 38.67 ± 1.15 146.58 ± 1.00a,c 44.68 ± 1.52b,c,d
Amylase (mg/dL) 48.67 ± 1.20 82.54 ± 0.57a,c 57.86 ± 3.05b,c,d
Lipase (mg/dL) 32.67 ± 2.08 56.33 ± 3.78a,c 41.00 ± 1.57b,c,d
CK (mg/dL) 30.33 ± 1.52 146.35 ± 0.88a,c 45.22 ± 0.57b,c,d
Serum protein
Total protein (g/dL) 7.20 ± 1.02 6.53 ± 3.80a,c 7.12 ± 0.17b,d
Albumin (g/dL) 3.72 ± 0.18 3.21 ± 1.53a,c 3.46 ± 0.34
Globulin (g/dL) 3.4 ± 1.57 3.02 ± 5.50a 3.2 ± 1.35b
Level of electrolytes in the serum
Sodium (mmol/L) 140 ± 3.10 152 ± 2.13a 142 ± 0.36b
Chloride (mmol/L) 104.33 ± 0.58 100.52 ± 1.97a,c 103.25 ± 1.52b
Bicarbonate (mmol/L) 24.48 ± 0.68 36.33 ± 1.52a,c 26.67 ± 0.88b,d
Magnesium (mmol/L) 1.93 ± 0.15 3.26 ± 0.12a,c 2.57 ± 0.59b,c,d
Calcium (mmol/L) 8.1 ± 0.85 10.27 ± 0.06a,c 8.6 ± 0.91b,c,d
Phosphorous (mmol/L) 5.07 ± 0.15 2.6 ± 1.35a,c 3.67 ± 0.12b,c,d
Group I: control (received saline intraperitoneally), group II: received sodium selenite (19 lmol/kg body weight) alone, group III: received
sodium selenite and treated with C-PC 200 mg/kg body weight from day 9 to 15
All values are expressed as mean ± SEM of three independent observations
a Statistically significant difference (p \ 0.05) when compared with group I and others
b Statistically significant difference (p \ 0.05) when compared with group II and III
c Statistically significant difference (p \ 0.01) when compared with group I and others
d Statistically significant difference (p \ 0.01) when compared with group II and I
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that plays a key role in regulating Na?/K? ATPase activity,
which is a crucial transmembrane regulator of Na? and K?
retention in the kidney and eye lens [27]. Overload of
sodium, phosphorous, calcium and magnesium contributes
to ATPase dysfunction and plasma electrolytes imbalance.
Ca2? levels in the lens is maintained at sub-micromolar
range by membrane bound Ca2? ATPases [28]. Research-
ers have reported that increased intracellular calcium
activates the calcium dependent cysteine protease and
calpain, leading to proteolysis of lens protein [29]. Accu-
mulation of endogenous calcium and other electrolytes in
the lenticular milieu remains the key factor for protein
aggregation and opacification [30].
2.5 General Serum Parameters
Serum biochemical parameters such as bilirubin, creati-
nine, urea, BUN, uric acid and plasma ammonia were also
analyzed to evaluate the degree of renal damage induced
by sodium selenite injection. All parameters mention were
elevated significantly in group II except plasma ammonia
(Table 2), thus conferring renal damage. Despite of the
toxicity exerted by sodium selenite, concurrent treatment
with C-PC controlled the levels of all the biochemical
parameters to near normal levels. Due to the hemolytic
property of sodium selenite [31], a significantly (p \ 0.05)
elevated bilirubin level (twofold increase) was noted in
selenite-induced group of pups. Microscopic anatomy of
kidney from control animals revealed regular structures of
renal corpuscles (RC) (Fig. 4). The kidney sections of
group II animals showed a high degree of scarification,
disorganized cellular morphology, loss of brush border,
vacuolization and desquamation of epithelial cells, and
such lesions were not predominately encountered in the
group III of animals treated with 200 mg/kg body weight
of C-PC. These findings suggest that the renal damage was
comparatively reduced on treating the rat pups with C-PC.
Impaired kidney function has been confirmed by the dis-
turbed histo-architecture of the tissue sections. The kidney
is the primary organ of sodium selenite toxicity and its
function is completely altered mainly due to it being the
major route of excretion of selenite [32]. Serum concen-
trations of creatinine, urea, ammonia and BUN are
important markers of protein catabolism and renal damage.
Fig. 3 Microscopic anatomy of liver tissue: viewed under 109
magnification (a–c) and 409 magnification (d–f). Liver sections of
control and treated groups showed regular morphology of the
hepatocytes (H) including the Portal Canal (PC). Sections of rat
liver induced with sodium selenite evidenced significant damage to
the hepatocytes with the appearance of pyknotic nucleus (PN) and
dilations in blood sinusoids (DBS). On treatment with C-PC the
deformation were minimal, although minimal damaged hepatocytes
were also observed
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Ostadalova [32] has recently reported that selenium tox-
icity has adverse effects on the ontogenic development and
its retention in suckling rat pups was observed in blood,
liver and kidney even after 7 days of administration.
During sodium selenite induced toxicity, dehydration is
inevitable, which may be the deciding factor causing the
rise in serum BUN. Elevated serum levels of urea, uric acid
and creatinine in sodium selenite induced pups demon-
strates renal impediment [33].
2.6 Antioxidant Enzyme Activities
The mean SOD and CAT enzyme activities were signifi-
cantly reduced in group II (selenite- induced) in compari-
son with group I. However, the activity was substantially
retained on C-PC treatment at the significant level
(p \ 0.05). The levels of GSH was reduced considerably in
the sodium selenite induced group (group II), but in the
C-PC treatment in group III, the treatment restored the
levels of GSH significantly to near placebo levels
(Table 2). Epidemiological studies reveal that the endog-
enous antioxidants such as SOD, CAT, and GSH of in lens
were decreased [34]. This imparts a direct correlation
between the blood anti-oxidant levels and cataract inci-
dence [35] that they could serve as systemic markers for
the identification of predisposed subjects. GSH is the chief
endogenous redox regulator and is drastically reduced
under oxidative stress. Our results are in accordance with
the earlier reports; that a reduction in anti-oxidant enzyme
levels in the hemolysate of group II animals is associated
evidence for enhanced oxidative stress and cataractogene-
sis. C-PC treatment in group III obviated the decline in
anti-oxidant status in the blood (Table 2). It is probable
that C-PC supplementation attenuates selenium toxicity
and cataractogenesis by conservation of thiol-related
processes.
3 Materials and Methods
3.1 Extraction of C-PC from S. platensis
S. platensis was cultured in Zarrouk’s media with pho-
toperiod of 12 h light and 12 h dark at pH 9.2. C-PC
was extracted by standard method as described in our
previous publication [21]. All the chemicals used in the
Fig. 4 Histology of the kidney tissue: viewed under 109 magnifi-
cation (a–c) and 409 magnification (d–f).The fixed sections of kidney
from the control rats showed normal histology with regular Renal
Corpuscles (RC), the functional unit of the kidneys. The kidney
sections of sodium selenite induced group of animals’ revealed
extensive degeneration (b, e). Group III kidney sections evidenced
marginal damage to the cellular morphology (c, f) however; the
normal histo-architecture was not completely restored
86 R. P. Kumari, K. Anbarasu
123
experiment were of analytical grade (HIMEDIA, Mum-
bai, India).
3.2 Experimental Design
Wistar rat pups both male and female (9 day old) were
used in the present study. The study protocol was approved
by the institutional ethical committee (Ref No. BDU/IAEC/
2012/42), Bharathidasan University, Tiruchirappalli. The
pups were housed with mothers in clean polypropylene
cages, maintained with a constant photoperiod of 12 h
dark/light cycle. They were fed with rodent-pelleted chow
and water ad libitum. These pups were randomly grouped
into control and two experimental groups, comprising of
eight pups per group (n = 8), and a total of 24 pups. On
postpartum day 10, group I (control) received vehicle
control saline alone, whereas group II and III were injected
with sodium selenite (19 lmol/kg body weight) subcuta-
neously. Group III simultaneously received 200 mg/kg
body weight of C-PC intraperitoneally on 9th day onwards
for five consecutive days in addition to sodium selenite on
10th day subcutaneously. Subsequently after 16 days of
birth, the rat pups were subjected to morphological
examination of the eye for cataract development and gra-
ded according to the degree of opacity developed. On 30th
day of postpartum, cataract formation was confirmed,
graded and the pups were sacrificed.
The blood samples were collected in tubes (BD vacu-
tainer), centrifuged at 5000 rpm for 20 min at 4 C; the
serum thus obtained was stored at 4 C until further ana-
lysis. Biochemical parameters were determined using a
Konelab20; a fully automated biochemical analyzer
(Thermo Scientific, Finland) and the electrolytes were
analyzed using a blood gas analyzer, (Siemens Rapid lab
348 Blood Gas Analyzer, Siemens Diagnostics, USA).
3.3 Plot Profiles of Lens Images
The rat lenses were imaged with a digital camera (Power
Shot A2200, Canon, India) and analyzed by ImageJ soft-
ware (http://rsbweb.nih.gov/ij/) to generate plot profiles of
pixel intensities and brightness along all points on a
selected line. Plot profile data were exported and plotted
using excel to calculate the arbitrary distribution of cataract
in all the group of lenses.
3.4 Biochemical Parameters
The following biochemical parameters were determined in
the sera of control and experimental group of rats: blood
urea nitrogen (BUN), urea, creatinine, uric acid, enzyme
activities such as AST, ALT, ALP, GGT, amylase, lipase,
CK and serum proteins (total protein, albumin and globu-
lin). Similarly, the electrolytes such as sodium, calcium,
magnesium, phosphorous, bicarbonate and chloride were
determined in sera by ion selective electrodes (ISE) using
blood gas analyzer.
Table 2 Status of creatinine, bilirubin, urea, BUN, plasma ammonia, uric acid in the serum and antioxidant enzyme activities in hemolysate of
control, sodium selenite induced and simultaneous C-PC treated group of animals
Parameters Group I (control) Group II (sodium selenite
induced, cataract untreated)
Group III (sodium selenite
induced, C-PC treated)
Creatinine (mg/dL) 0.8 ± 0.15 0.92 ± 0.1.12a 0.766 ± 0.06b
Billirubin (mg/dL) 0.5 ± 0.25 1.1 ± 0.85a,c 0.63 ± 0.15b,d
Urea (mg/dL) 30.0 ± 0.58 42 ± 0.51a,c 31.67 ± 2.96b,d
BUN (mg/dL) 13.33 ± 1.15 19.31 ± 0.58a,c 13.57 ± 0.18b,d
Plasma ammonia (mg/dL) 40.95 ± 0.15 36.41 ± 0.57a,c 42.0 ± 2.64b
Uric acid (mg/dL) 4.13 ± 0.08 5.82 ± 0.07a,c 3.53 ± 0.03b,d
Antioxidant enzyme activities in hemolysate
SOD (unit/g Hb) 165.94 ± 2.67 129.0 ± 0.89a 157.86 ± 2.37b
CAT (lmol of H2O2 consumed/min/g Hb) 208.56 ± 0.92 120.86 ± 1.24
a 166.61 ± 0.77b
GSH (mmol/g of Hb) 237.71 ± 2.13 162.41 ± 1.73a 198.55 ± 1.69b
Group I: control (received saline intraperitoneally), group II: received sodium selenite (19 lmol/kg body weight) alone, group III: received
sodium selenite and treated with C-PC 200 mg/kg body weight from day 9 to 15
All values are expressed as mean ± SEM of three independent observations
a Statistically significant difference (p \ 0.05) when compared with group I and others
b Statistically significant difference (p \ 0.05) when compared with group II and III
c Statistically significant difference (p \ 0.01) when compared with group I and others
d Statistically significant difference (p \ 0.01) when compared with group II and I
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3.5 Preparation of Hemolysate
Anti-coagulated blood obtained from all the three groups of
animals was centrifuged at 3000 rpm for 5 min at 4 C.
The packed cells were washed with isotonic buffer, fol-
lowed by lysis with hypotonic buffer. The lysed cells were
further centrifuged to separate the hemolysate (superna-
tant) [36]. The samples were stored at -20 C until
analysis.
3.6 Antioxidant Enzyme Activities in Hemolysate
Superoxide dismutase was assayed spectrometrically in a
UV–VIS spectrophotometer (Jasco V-550, USA) as descri-
bed by Marklund [37] and the enzyme activity was expressed
as unit/g Hb. CAT activity was assayed according to the
method of Sinha [38] and the enzyme activity was expressed
as micromoles of H2O2 consumed per minute per gram Hb.
GSH was measured by the method of Moron [39]. The
amount of GSH present in the hemolysate was expressed as
millimole/gram of Hb. GSH was maintained as standard for
establishing calibration curve.
3.7 Histological Studies
Animals were sacrificed at the end of intended experi-
mental period (30th day). The liver, kidney, eye lens tis-
sues were separated, cleaned and diced into 0.5 cubic cm in
size. Then the tissue was fixed in 10 % buffered formal-
dehyde (pH 7.4) at room temperature overnight. The fixed
tissue was dehydrated with series of ethanol in order to
remove water and infiltrated with paraffin wax. The blocks
were cut into 5 lm thickness using rotary microtome and
the sections were stained with Haematoxylin and Eosin.
The cellular morphology and architecture was analyzed
using a Nikon Microscope; Eclipse 80i.
3.8 Statistical Analysis
All values are expressed as mean ± standard error of the
mean (SEM). The statistical analysis of data was performed
using one-way analysis of variance (ANOVA) followed by
Student’s Newman-Keul’s test (SNK) using the Statistical
Package for Social Sciences (SPSS) software package for
Windows (Version 16.0; IBM Corporation, Armonk, NY,
USA). The critical significance levels was considered at the
level of p \ 0.05 and p \ 0.01.
4 Conclusion
Oxidative stress is a crucial factor in the patho-physiology
of sodium selenite induced toxicity and cataractogenesis
[40]. The results collated in this study agree with the earlier
reports that sodium selenite causes cytotoxicity, catarac-
togenesis and apoptosis mediated by increasing intracel-
lular reactive oxygen species in the eye lens, kidney and
liver.
Cataract and aging evoke numerous physicochemical
changes in the lens proteins. We have previously reported
that effects of C-PC, a billiprotein pigment in the incidence
of selenite-induced cataract both in vitro and in vivo [21].
It has been documented that C-PC evades oxidative stress
and related cellular damages by scavenging the free radi-
cals and chelating metal ions [41]. The principle compo-
nent tetrapyrrole chromophore present in the pigment
bestows the radical scavenging property of C-PC [42].
C-PC has not only been reported for its anti-oxidant
capacity but it also possess well established anti-apoptotic
effects [27]. Administration of C-PC in the present study
shows considerable reduction in cataractogenic process and
subsequent damage to the eye lens, liver and kidney.
Results also affirm the appreciable improvement of sec-
ondary serum markers of selenite toxicity and cataracto-
genesis. From our results it is suggested that C-PC
positively modulates hepatic function by the reduction of
oxidative stress and also the imbalance in electrolytes is
shifted towards equilibrium. Lim [42] has established that
C-PC attenuates cisplatin induced nephrotoxicity by
decreasing the expression of p-ERK, p-JNK, p-p38, Bax,
caspase-9, and caspase-3. Our serum biochemical and
histology study further confirms that 200 mg/kg body
weight C-PC reduces the impairment caused by sodium
selenite toxicity probably by scavenging the free radical
generated and exerting anti-apoptotic function.
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